Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Opinion Article - (2023) Volume 15, Issue 3

Predicting the Clinical Outcomes of Bacterial Infections in Critically Ill Patients through Therapeutic Amoxicillin Drug Administration
Miguel Trusha*
 
Department of Pharmaceutical Care, University of Phayao, Phayao, Thailand
 
*Correspondence: Miguel Trusha, Department of Pharmaceutical Care, University of Phayao, Phayao, Thailand, Email:

Received: 29-May-2023, Manuscript No. JBB-23-22173; Editor assigned: 02-Jun-2023, Pre QC No. JBB-23-22173 (PQ); Reviewed: 16-Jun-2023, QC No. JBB-23-22173; Revised: 23-Jun-2023, Manuscript No. JBB-23-22173 (R); Published: 30-Jun-2023, DOI: 10.35248/0975-0851.23.15.525

Description

Amoxicillin is a widely prescribed antibiotic which has revolutionized the field of medicine since its introduction in the 1970s. Belonging to the class of penicillins, it has gained recognition as a safe and effective treatment for various bacterial infections. The discovery of penicillin by Alexander Fleming in 1928 laid the foundation for the development of antibiotics. Building upon this breakthrough, scientists modified the penicillin molecule, resulting in the synthesis of amoxicillin in the 1970s. This semi-synthetic derivative exhibited improved stability, increased spectrum of activity, and enhanced bioavailability compared to its predecessors. Amoxicillin rapidly gained popularity, becoming a cornerstone antibiotic in the treatment of numerous bacterial infections. Amoxicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It does so by interfering with the enzymes responsible for cross-linking the peptidoglycan strands, a crucial component of the bacterial cell wall. This disruption weakens the structural integrity of the cell wall, leading to bacterial cell lysis and ultimately death. Additionally, amoxicillin exhibits bactericidal activity against susceptible bacteria (i.e., it directly kills the target pathogens). Amoxicillin finds extensive use in the treatment of both common and severe bacterial infections. It is commonly prescribed for respiratory tract infections, including bronchitis, pneumonia, and sinusitis. Furthermore, it is highly effective against skin and soft tissue infections, urinary tract infections, otitis media, and certain sexually transmitted diseases caused by susceptible organisms.

Amoxicillin is also utilized as a prophylactic antibiotic to prevent infections during certain medical procedures, such as dental work and surgery. Amoxicillin is generally safe and well tolerated by most patients. However, like any other drug, this amoxicillin can have potential side effects. The most common adverse reactions include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. These effects are usually mild and transient. Allergic reactions, although rare, can occur and range from mild skin rashes to severe anaphylaxis, a life-threatening condition. It is crucial for healthcare professionals to be vigilant and consider a patient's medical history, particularly regarding hypersensitivity to penicillins, before prescribing amoxicillin. The emergence of antibiotic resistance poses a significant challenge in the field of healthcare. Over time bacteria have developed mechanisms to evade the effects of antibiotics, including amoxicillin. This necessitates a judicious and responsible use of antibiotics to prevent the further spread of resistance.

Moreover, ongoing research aims to develop novel antibiotics or combination therapies to combat resistant strains effectively. As advancements in genomic sequencing and diagnostic techniques continue, clinicians may be able to find antibiotic therapy to individual patients. By identifying the specific bacterial strain causing an infection and determining its susceptibility to different antibiotics, healthcare providers can optimize treatment plans, ensuring the most effective and targeted use of amoxicillin.

Amoxicillin has undoubtedly revolutionized the field of medicine as a cornerstone antibiotic. Its efficacy, safety profile, and broad spectrum of activity have made it an indispensable tool in combating bacterial infections. However, the rise of antibiotic resistance demands a cautious approach in prescribing and using this medication. Continued research and development in the field of antibiotics are essential to overcome the challenges posed by resistant bacterial strains. With responsible use and further innovations, amoxicillin will remain a vital therapeutic agent, providing relief to countless patients suffering from bacterial infections.

Amoxicillin is available as capsules, tablets, chewable tablets, and oral suspension (liquid). In general, take this medicine every 12 hours (twice a day) or every 8 hours (three times a day) with or without food. The type of infection determines how long the treatment will last. Amoxicillin should be taken every day around the same time. Amoxicillin may also be used to treat Lyme disease, prevent post-exposure anthrax infection, and treat cutaneous anthrax infection. Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow the regular dosing schedule.

Dosage depends on a person’s medical condition and their response to treatment. Take plenty of fluids while using this medicine. Continue taking the medicine until the prescribed amount is used up, even if the symptoms disappear after a few days. If the drug is stopped so early, the bacteria can continue to grow and the infection may return.

Citation: Trusha M (2023) Predicting the Clinical Outcomes of Bacterial Infections in Critically Ill Patients through Therapeutic Amoxicillin Drug Administration. J Bioequiv Availab. 15:525

Copyright: © 2023 Trusha M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.